Botulinum toxin type A (BTX) injections are frequently used in children with cerebral palsy (CP) to control spasticity. Injection variables still lead to variable outcomes of this treatment. Using instrumented spasticity assessment and muscle volume assessment the most effective location of the injection was demonstrated for gracilis and psoas muscles in children with CP. It was found that this treatment is most effective when injected in the motor endplate zones of the selected muscles. This review article presents all available research on the role of motor endplate-targeting of BTX injections in children with CP.
|Number of pages||5|
|Journal||Acta orthopaedica Belgica|
|Publication status||Published - 1 Jan 2015|
- Botulinum toxin
- Cerebral palsy
- Motor end plate